Oncopeptides AB (publ) announced that Henrik Bergentoft on November 13, 2023 takes office as the company´s new Chief Financial Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.78 SEK | -3.97% | -16.77% | -63.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.71% | 59.34M | |
+9.34% | 114B | |
+11.55% | 104B | |
-13.77% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.24% | 17.89B | |
+7.45% | 14.28B | |
+35.53% | 12.55B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides AB Appoints Henrik Bergentoft as Chief Financial Officer